within Pharmacolibrary.Drugs.ATC.V;

model V09IX02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.9999999999999997e-06,
    adminDuration  = 600,
    adminMass      = 3700 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.004900000000000001,
    k12             = 0.22,
    k21             = 0.22
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V09IX02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Iobenguane (131I), also known as 131I-metaiodobenzylguanidine (131I-MIBG), is a radiopharmaceutical agent used primarily for diagnostic imaging and treatment of certain types of neuroendocrine tumors, such as pheochromocytoma and neuroblastoma. It is labeled with radioactive iodine-131 and selectively taken up by adrenergic tissue. 131I-MIBG is currently approved for therapeutic use in metastatic or relapsed high-risk neuroblastoma.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as reported in adult patients undergoing therapy for neuroendocrine tumors; data from published clinical studies and product information.</p><h4>References</h4><ol><li><p>Casáns-Tormo, I, et al., &amp; Ruano-Pérez, R (2019). Cardiac sympathetic innervation scintigraphy with . <i>Revista espanola de medicina nuclear e imagen molecular</i> 38(4) 262–271. DOI:<a href=&quot;https://doi.org/10.1016/j.remn.2019.01.001&quot;>10.1016/j.remn.2019.01.001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31031167/&quot;>https://pubmed.ncbi.nlm.nih.gov/31031167</a></p></li><li><p>Kline, RC, et al., &amp; Beierwaltes, WH (1981). Myocardial imaging in man with I-123 meta-iodobenzylguanidine. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 22(2) 129–132. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7463156/&quot;>https://pubmed.ncbi.nlm.nih.gov/7463156</a></p></li><li><p>Défachelles, AS, et al., &amp; Carpentier, P (2011). [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications]. <i>Bulletin du cancer</i> 98(5) 559–569. DOI:<a href=&quot;https://doi.org/10.1684/bdc.2011.1353&quot;>10.1684/bdc.2011.1353</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21609890/&quot;>https://pubmed.ncbi.nlm.nih.gov/21609890</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V09IX02;
